Gaithersburg, MD, United States of America

Panacea Pharmaceuticals, Inc.

USPTO Granted Patents = 8

% Expired Patents = 75.0



Forward Citations = 51

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Hossein A Ghanbari (4 out of 11 patents)

silverMedal Michael Lebowitz (3 out of 6 patents)

bronzeMedal Carl R Merril (3 out of 28 patents)

4.  Biswajit Biswas (2 out of 4 patents)

5.  Natalie Ostretova-Golts (2 out of 2 patents)

6.  Benjamin Wolozin (2 out of 3 patents)

7.  Michael J Caplan (1 out of 14 patents)

8.  Zhi-Gang Jiang (1 out of 3 patents)

9.  Howard B Sosin (1 out of 10 patents)

10.  Hugh A Sampson (1 out of 20 patents)

11.  Bijan Almassian (1 out of 3 patents)

12.  Weiying Pan (1 out of 1 patent)

13.  Alan H Deutch (8 patents)

14.  Jack Raymond Wands (60 patents)

15.  Suzanne De La Monte (4 patents)


8 patents:

Company Overview
Panacea Pharmaceuticals, Inc. is a biotechnology company dedicated to developing and commercializing novel cancer therapeutics. With a focus on precision medicine, Panacea works to personalize treatment options for patients based on their unique genetic profiles. The company's innovative approach has led to several successful clinical trials and promising drug candidates in the pipeline.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#56 in Gaithersburg, MD

#505 in Maryland

#35,941 in US

Gaithersburg, MD (US)
Gaithersburg, MD, United States of America
Forward Citations = 51

12 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Panacea Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/panacea-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…